These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
554 related items for PubMed ID: 24504805
1. Therapeutic effect of human amniotic membrane-derived cells on experimental arthritis and other inflammatory disorders. Parolini O, Souza-Moreira L, O'Valle F, Magatti M, Hernandez-Cortes P, Gonzalez-Rey E, Delgado M. Arthritis Rheumatol; 2014 Feb; 66(2):327-39. PubMed ID: 24504805 [Abstract] [Full Text] [Related]
2. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells. González MA, Gonzalez-Rey E, Rico L, Büscher D, Delgado M. Arthritis Rheum; 2009 Apr; 60(4):1006-19. PubMed ID: 19333946 [Abstract] [Full Text] [Related]
3. Therapeutic effect of urocortin on collagen-induced arthritis by down-regulation of inflammatory and Th1 responses and induction of regulatory T cells. Gonzalez-Rey E, Chorny A, Varela N, O'Valle F, Delgado M. Arthritis Rheum; 2007 Feb; 56(2):531-43. PubMed ID: 17265488 [Abstract] [Full Text] [Related]
4. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis. Joosten LA, Lubberts E, Helsen MM, Saxne T, Coenen-de Roo CJ, Heinegård D, van den Berg WB. Arthritis Res; 1999 Feb; 1(1):81-91. PubMed ID: 11056663 [Abstract] [Full Text] [Related]
6. The programmed death 1/programmed death ligand 1 inhibitory pathway is up-regulated in rheumatoid synovium and regulates peripheral T cell responses in human and murine arthritis. Raptopoulou AP, Bertsias G, Makrygiannakis D, Verginis P, Kritikos I, Tzardi M, Klareskog L, Catrina AI, Sidiropoulos P, Boumpas DT. Arthritis Rheum; 2010 Jul; 62(7):1870-80. PubMed ID: 20506224 [Abstract] [Full Text] [Related]
7. Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses. González MA, Gonzalez-Rey E, Rico L, Büscher D, Delgado M. Gastroenterology; 2009 Mar; 136(3):978-89. PubMed ID: 19135996 [Abstract] [Full Text] [Related]
8. Therapeutic effect of cortistatin on experimental arthritis by downregulating inflammatory and Th1 responses. Gonzalez-Rey E, Chorny A, Del Moral RG, Varela N, Delgado M. Ann Rheum Dis; 2007 May; 66(5):582-8. PubMed ID: 17151007 [Abstract] [Full Text] [Related]
9. Oleanolic acid acetate inhibits rheumatoid arthritis by modulating T cell immune responses and matrix-degrading enzymes. Choi JK, Kim SW, Kim DS, Lee JY, Lee S, Oh HM, Ha YS, Yoo J, Park PH, Shin TY, Kwon TK, Rho MC, Kim SH. Toxicol Appl Pharmacol; 2016 Jan 01; 290():1-9. PubMed ID: 26570984 [Abstract] [Full Text] [Related]
10. IL-37 Alleviates Rheumatoid Arthritis by Suppressing IL-17 and IL-17-Triggering Cytokine Production and Limiting Th17 Cell Proliferation. Ye L, Jiang B, Deng J, Du J, Xiong W, Guan Y, Wen Z, Huang K, Huang Z. J Immunol; 2015 Jun 01; 194(11):5110-9. PubMed ID: 25917106 [Abstract] [Full Text] [Related]
11. Germinal center kinase-like kinase overexpression in T cells as a novel biomarker in rheumatoid arthritis. Chen YM, Chuang HC, Lin WC, Tsai CY, Wu CW, Gong NR, Hung WT, Lan TH, Lan JL, Tan TH, Chen DY. Arthritis Rheum; 2013 Oct 01; 65(10):2573-82. PubMed ID: 23817999 [Abstract] [Full Text] [Related]
12. Interleukin-6 receptor blockade enhances CD39+ regulatory T cell development in rheumatoid arthritis and in experimental arthritis. Thiolat A, Semerano L, Pers YM, Biton J, Lemeiter D, Portales P, Quentin J, Jorgensen C, Decker P, Boissier MC, Louis-Plence P, Bessis N. Arthritis Rheumatol; 2014 Feb 01; 66(2):273-83. PubMed ID: 24504799 [Abstract] [Full Text] [Related]
14. α2β1 integrin regulates Th17 cell activity and its neutralization decreases the severity of collagen-induced arthritis. El Azreq MA, Boisvert M, Cesaro A, Pagé N, Loubaki L, Allaeys I, Chakir J, Poubelle PE, Tessier PA, Aoudjit F. J Immunol; 2013 Dec 15; 191(12):5941-50. PubMed ID: 24244022 [Abstract] [Full Text] [Related]
15. Intervention of an inflammation amplifier, triggering receptor expressed on myeloid cells 1, for treatment of autoimmune arthritis. Murakami Y, Akahoshi T, Aoki N, Toyomoto M, Miyasaka N, Kohsaka H. Arthritis Rheum; 2009 Jun 15; 60(6):1615-23. PubMed ID: 19479878 [Abstract] [Full Text] [Related]
16. Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis. Palmer G, Talabot-Ayer D, Lamacchia C, Toy D, Seemayer CA, Viatte S, Finckh A, Smith DE, Gabay C. Arthritis Rheum; 2009 Mar 15; 60(3):738-49. PubMed ID: 19248109 [Abstract] [Full Text] [Related]
17. Is Taurolidine a candidate for treatment of rheumatoid arthritis? Marcinkiewicz J, Głuszko P, Kontny E, Kwaśny-Krochin B, Bobek M, Wierzchowski W, Ciszek M, Maśliński W. Clin Exp Rheumatol; 2007 Mar 15; 25(2):211-8. PubMed ID: 17543144 [Abstract] [Full Text] [Related]
18. Extracorporeal photopheresis reduces inflammation and joint damage in a rheumatoid arthritis murine model. Lin Y, Cheng Z, Zhong Y, Zhao Y, Xiang G, Li L, Tian L, Liu Z. J Transl Med; 2024 Mar 25; 22(1):305. PubMed ID: 38528553 [Abstract] [Full Text] [Related]
19. Endogenous myeloperoxidase is a mediator of joint inflammation and damage in experimental arthritis. Odobasic D, Yang Y, Muljadi RC, O'Sullivan KM, Kao W, Smith M, Morand EF, Holdsworth SR. Arthritis Rheumatol; 2014 Apr 25; 66(4):907-17. PubMed ID: 24757143 [Abstract] [Full Text] [Related]
20. Regulation of apoptosis and inflammatory responses by insulin-like growth factor binding protein 3 in fibroblast-like synoviocytes and experimental animal models of rheumatoid arthritis. Lee HS, Woo SJ, Koh HW, Ka SO, Zhou L, Jang KY, Lim HS, Kim HO, Lee SI, Park BH. Arthritis Rheumatol; 2014 Apr 25; 66(4):863-73. PubMed ID: 24757139 [Abstract] [Full Text] [Related] Page: [Next] [New Search]